A semi-pharmaceutical approach for the preparation of an anti-IL2 receptor monoclonal antibody in the treatment of acute GvHD in a multicentric study.

Source:http://linkedlifedata.com/resource/pubmed/id/2205522

Download in:

View as

General Info

PMID
2205522